Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial.
Saved in:
| Title: | Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial. |
|---|---|
| Authors: | Brody JD; Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY., Jørgensen J; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Belada D; 4th Department of Internal Medicine, Hematology, University Hospital and Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic., Costello R; Service d'Hematologie et Thérapie Cellulaire, Assistance Publique Hôpitaux de Marseille, Marseille, France., Trněný M; First Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Vitolo U; Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy., Lewis DJ; Department of Haematology, Derriford Hospital, University Hospitals Plymouth National Health Service Trust, Plymouth, United Kingdom., Karimi YH; University of Michigan Division of Hematology & Oncology, Ann Arbor, MI., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia, L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., André M; Service d'Hématologie, Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir, Belgium., Wahlin BE; Division of Haematology, Department of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Jiang T; Oncology Clinical Development, AbbVie, North Chicago, IL., Karagoz K; Translational Data Science, Genmab, Plainsboro, NJ., Steele AJ; Translational Medicine, Genmab, Plainsboro, NJ., Abbas A; Clinical Science, Genmab, Plainsboro, NJ., Wang L; Biostatistics, Genmab, Plainsboro, NJ., Risum M; Medical, Genmab, Copenhagen, Denmark., Cordoba R; Department of Hematology, Fundación Jiménez Diaz University Hospital, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Madrid, Spain. |
| Source: | Blood [Blood] 2025 Apr 10; Vol. 145 (15), pp. 1621-1631. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study; Clinical Trial, Phase I |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
